Inflammation of nervous-system tissue, a target in many neuro protocols.
Chronic, low-level immune activation in the brain and spinal cord—distinct from acute infection—implicated in Parkinson's, Alzheimer's, and multiple sclerosis. Stem cells are studied for neuroinflammation because they release anti-inflammatory signals that cross the blood-brain barrier. Clinics treating neurological conditions often invoke neuroinflammation, which is scientifically sound, but brain delivery is mechanically challenging; cells injected intravenously or intrathecally may not reach all inflamed regions. Ask clinics how they ensure distribution and whether they monitor neuroinflammatory markers (glial activation, cytokine panels) before and after treatment to prove the mechanism.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment